2004
DOI: 10.1021/ol047859w
|View full text |Cite
|
Sign up to set email alerts
|

Late-Stage Intermolecular CH Activation for Lead Diversification:  A Highly Chemoselective Oxyfunctionalization of the C-9 Position of Potent Bryostatin Analogues

Abstract: Treatment of highly potent and densely functionalized bryostatin analogue 1 with dimethyldioxirane afforded the C-9 hydroxylated hemiketal 2 via oxyfunctionalization of the C9-CH bond, one of 12 CH bonds geminal to an oxygen substituent in 1. When bryostatin analogue 3 was subjected to identical conditions, oxidation of a C-26 secondary hydroxyl group was found to compete with C-9 hydroxylation. Complete selectivity for C-9 hydroxylation was restored upon acylation of the C-26 secondary alcohol.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
46
0
3

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 93 publications
(49 citation statements)
references
References 36 publications
0
46
0
3
Order By: Relevance
“…[206] Despite this fact, Wender et al achieved remarkable selectivity in the late-stage oxidation of bryostatin analogues with DMDO. [207] Treatment of 235 with two equivalents of freshly prepared DMDO resulted in stereospecific C À H oxidation at the C9-position to give 236, despite the presence of a myriad of other sensitive functional groups including two alkenes, multiple ethereal bonds, a free primary hydroxy, and tertiary CÀH bonds, all of which are susceptible to oxidation (Scheme 99). Given the highly electrophilic nature of this oxidant, [208] it is not surprising that the acrylic ester alkene was not epoxidized.…”
Section: Metal-catalyzed C à H Activationmentioning
confidence: 99%
“…[206] Despite this fact, Wender et al achieved remarkable selectivity in the late-stage oxidation of bryostatin analogues with DMDO. [207] Treatment of 235 with two equivalents of freshly prepared DMDO resulted in stereospecific C À H oxidation at the C9-position to give 236, despite the presence of a myriad of other sensitive functional groups including two alkenes, multiple ethereal bonds, a free primary hydroxy, and tertiary CÀH bonds, all of which are susceptible to oxidation (Scheme 99). Given the highly electrophilic nature of this oxidant, [208] it is not surprising that the acrylic ester alkene was not epoxidized.…”
Section: Metal-catalyzed C à H Activationmentioning
confidence: 99%
“…Another illustrative general example of successful modification of biologically active compounds, structurally unrelated to sesqiterpene quinones, is the attempt to simplify structures of bryostatin-1 (61, Figure 21), a powerful antineoplastic macrolide from a marine bryozoan (128,129) and to establish SAR requirements [128,129] for preserving its exceptional pharmacological properties. In a series of experiments, important discoveries and goals were achieved: a) the experimental data validate the design of the simplified pharmacological model structure; b) the newly developed analogues 62 and 63 ( Figure 21) have in vitro and in vivo biological activities similar or higher than bryostatin and c) by practical total synthesis, the analogues are made available in sufficient amounts for clinical trials.…”
Section: Marine Pharmacology: Perspectivesmentioning
confidence: 99%
“…These C26 and C3 positions benefit from similar hyperconjugative donation from adjacent oxygen lone pairs, though their proximity to a number of EWGs presumably deactivates the C–H bonds (Figure 30G). 208 The reactivity of C9 over other α -ethereal positions is excellent. In comparing C9–H and C5–H, the latter is likely deactivated due to the remote electron withdrawing nature of the C1 ester, and C11–H and C15–H are less favorable to oxidize due to the oxocarbenium character of both ethers in this ring.…”
Section: C–h Oxidationmentioning
confidence: 99%